SAN FRANCISCO, CA USA (UroToday.com) - Presented by Peter J. Goebell, Ulrich Kube, Michael Staehler, Christian Doehn, Thomas Steiner, Manfred Kindler, Edwin Herrmann, Jan Janssen, Steffen Weikert, Michael Thomas Scheffler, Joerg Schmitz, Friedrich Overkamp, Gernot Guderian, Michael Albrecht, and Lothar Bergmann at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Department of Urology, Friedrich-Alexander University Erlangen, Erlangen, Germany; Private Practice for Oncology, Chemnitz, Germany; Department of Urology, University of Munich, Munich, Germany; Urologikum Lübeck, Lübeck, Germany; Helios-Klinikum Erfurt, Klinik für Urologie, Erfurt, Germany; Private Practice for Oncology, Berlin, Germany; Department of Urology, University of Münster, Münster, Germany; Private Practice for Oncology, Westerstede, Germany; Charité Campus Mitte, Berlin, Germany; Praxis Dr. Scheffler, Zwickau, Germany; Kliniken der Stadt Köln Merheim, Cologne, Germany; Praxis und Tagesklinik für Internistische Onkologie, Recklinghausen, Germany; Novartis Pharma GmbH, Nuermberg, Germany; Department Drug Safety & Epidemiology, Novartis Pharma GmbH, Nuremberg, Germany; Klinikum der Johann-Wolfgang-Goethe Universität, Medizinische Klinik III, Tumorzentrum Rhein-Main,, Frankfurt/Main, Germany